These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7539451)

  • 21. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.
    Manzotti CN; Tipping H; Perry LC; Mead KI; Blair PJ; Zheng Y; Sansom DM
    Eur J Immunol; 2002 Oct; 32(10):2888-96. PubMed ID: 12355442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An appraisal of T cell subsets and the potential for autoimmune injury.
    Kelly CJ; Frishberg Y; Gold DP
    Kidney Int; 1998 Jun; 53(6):1574-84. PubMed ID: 9607187
    [No Abstract]   [Full Text] [Related]  

  • 23. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses.
    Wang S; Chen L
    Microbes Infect; 2004 Jul; 6(8):759-66. PubMed ID: 15207823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of CD28/CTLA4-B7 pathway prevented autoantibody-related diseases but not lung disease in MRL/lpr mice.
    Takiguchi M; Murakami M; Nakagawa I; Yamada A; Chikuma S; Kawaguchi Y; Hashimoto A; Uede T
    Lab Invest; 1999 Mar; 79(3):317-26. PubMed ID: 10092068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
    Watanabe N; Gavrieli M; Sedy JR; Yang J; Fallarino F; Loftin SK; Hurchla MA; Zimmerman N; Sim J; Zang X; Murphy TL; Russell JH; Allison JP; Murphy KM
    Nat Immunol; 2003 Jul; 4(7):670-9. PubMed ID: 12796776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
    J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential requirements of naïve and memory T cells for CD28 costimulation in autoimmune pathogenesis.
    Perrin PJ; Lovett-Racke A; Phillips SM; Racke MK
    Histol Histopathol; 1999 Oct; 14(4):1269-76. PubMed ID: 10506942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.
    Linsley PS; Bradshaw J; Urnes M; Grosmaire L; Ledbetter JA
    J Immunol; 1993 Apr; 150(8 Pt 1):3161-9. PubMed ID: 7682233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When ligand becomes receptor--tolerance via B7 signaling on DCs.
    Finger EB; Bluestone JA
    Nat Immunol; 2002 Nov; 3(11):1056-7. PubMed ID: 12407416
    [No Abstract]   [Full Text] [Related]  

  • 31. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis.
    Cross AH; Lyons JA; San M; Keeling RM; Ku G; Racke MK
    Eur J Immunol; 1999 Oct; 29(10):3140-7. PubMed ID: 10540325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS; Denton MD; Chandraker A; Knoflach A; Milord R; Waaga AM; Turka LA; Russell ME; Peach R; Sayegh MH
    Am J Pathol; 2001 Mar; 158(3):977-86. PubMed ID: 11238045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80.
    Boulougouris G; McLeod JD; Patel YI; Ellwood CN; Walker LS; Sansom DM
    J Immunol; 1998 Oct; 161(8):3919-24. PubMed ID: 9780158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
    Prud'homme GJ; Chang Y; Li X
    Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease.
    Karandikar NJ; Vanderlugt CL; Bluestone JA; Miller SD
    J Neuroimmunol; 1998 Aug; 89(1-2):10-8. PubMed ID: 9726820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging role of CTLA-4 as an immune attenuator.
    Thompson CB; Allison JP
    Immunity; 1997 Oct; 7(4):445-50. PubMed ID: 9354465
    [No Abstract]   [Full Text] [Related]  

  • 38. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
    Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
    J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental murine schistosomiasis in the absence of B7 costimulatory molecules: reversal of elicited T cell cytokine profile and partial inhibition of egg granuloma formation.
    Hernandez HJ; Sharpe AH; Stadecker MJ
    J Immunol; 1999 Mar; 162(5):2884-9. PubMed ID: 10072537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.